In atopic dermatitis, EPISODIC CONTROL MAY
NOT GET TO THE CORE
OF THE PROBLEM.1–3
Suárez-Fariñas M, et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol. 2011;127(4):954-964. © Elsevier Editeur. All rights reserved. Used with permission.
Immunohistochemistry (IHC) staining of terminal differentiation proteins in clinically uninfected/nonlesional atopic dermatitis (ANL), lesional atopic dermatitis (AL), and normal skin. Based on genomic and histologic profiling of both ANL and AL skin lesions (n=12, each), compared with normal human skin (n=10). Scale bar=100 µm.
Current findings show that nonlesional skin exhibits subclinical defects similar to lesional skin, including1,2,4:
In some patients, skin barrier dysfunction, resulting from either genetic defects and/or Th2 immunologic defects, ultimately5,6:
Nonlesional skin in patients with atopic dermatitis is not histologically normal and is indicative of the subclinical inflammation inherent to atopic dermatitis.1,2